Published in Biochem J on April 01, 1992
Hyaluronan as an immune regulator in human diseases. Physiol Rev (2011) 2.74
Expression of human hyaluronan synthases in response to external stimuli. Biochem J (2000) 1.29
Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury. Am J Respir Cell Mol Biol (2005) 1.18
Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-beta 1 involves activation of protein kinase C. Biochem J (1995) 1.09
The activity of hyaluronan synthase 2 is regulated by dimerization and ubiquitination. J Biol Chem (2010) 1.04
Modulation of hyaluronan synthase activity in cellular membrane fractions. J Biol Chem (2009) 0.99
Cyclic movement stimulates hyaluronan secretion into the synovial cavity of rabbit joints. J Physiol (2008) 0.97
Recombinant human hyaluronan synthase 3 is phosphorylated in mammalian cells. Biochem J (2006) 0.95
Hyaluronan - a functional and structural sweet spot in the tissue microenvironment. Front Immunol (2015) 0.93
Hyaluronan secretion by synoviocytes is mechanosensitive. Matrix Biol (2005) 0.92
Transforming growth factor-beta 1 (TGF-beta 1)- and beta 2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer. Clin Exp Immunol (1994) 0.90
Regulation of hyaluronan secretion into rabbit synovial joints in vivo by protein kinase C. J Physiol (2003) 0.86
Pleural mesothelial cells in pleural and lung diseases. J Thorac Dis (2015) 0.86
Cloning and characterization of cell strains derived from human corneal stroma and sclera. Jpn J Ophthalmol (2010) 0.85
Hyaluronan stimulates pancreatic cancer cell motility. Oncotarget (2016) 0.83
Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy. J Clin Invest (1995) 0.81
Prostaglandin E2 stimulates cyclic AMP-mediated hyaluronan synthesis in rabbit pericardial mesothelial cells. Biochem J (1993) 0.78
Signal pathways regulating hyaluronan secretion into static and cycled synovial joints of rabbits. J Physiol (2009) 0.76
Hyaluronan production and hyaluronan synthase expression in three human conjunctiva-derived cell strains. Jpn J Ophthalmol (2011) 0.75
The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell (1982) 19.91
Determination of protein: a modification of the Lowry method that gives a linear photometric response. Anal Biochem (1972) 19.75
Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro. Cell (1989) 6.88
The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell (1982) 4.17
PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation on tyrosine residues 783 and 1254. Cell (1991) 3.95
Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci U S A (1986) 3.04
Inhibition of membrane phosphotyrosyl-protein phosphatase activity by vanadate. Biochem Biophys Res Commun (1982) 3.01
Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells. Mol Cell Biol (1989) 2.78
Platelet-derived growth factor: mechanism of action and possible in vivo function. Cell Regul (1990) 2.31
Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell (1983) 2.02
Hyaluronate and invasiveness of the rabbit V2 carcinoma. Proc Natl Acad Sci U S A (1979) 1.96
Hyaluronate is synthesized at plasma membranes. Biochem J (1984) 1.95
Synthesis of hyaluronate in differentiated teratocarcinoma cells. Mechanism of chain growth. Biochem J (1983) 1.91
Synthesis of hyaluronate in differentiated teratocarcinoma cells. Characterization of the synthase. Biochem J (1983) 1.76
Increased hyaluronate synthesis is required for fibroblast detachment and mitosis. Biochem J (1986) 1.72
The role and regulation of tumour-associated hyaluronan. Ciba Found Symp (1989) 1.68
Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J (1989) 1.49
Expression of three recombinant homodimeric isoforms of PDGF in Saccharomyces cerevisiae: evidence for difference in receptor binding and functional activities. Growth Factors (1989) 1.45
Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res (1987) 1.30
Agents that increase cAMP accumulation block endothelial c-sis induction by thrombin and transforming growth factor-beta. J Biol Chem (1987) 1.26
The effect of cell density on net rates of glycosaminoglycan synthesis and secretion by cultured rat fibroblasts. J Biol Chem (1980) 1.24
Induction of hyaluronic acid synthetase activity in rat fibroblasts by medium change of confluent cultures. J Cell Physiol (1975) 1.24
Raised serum hyaluronate levels in scleroderma: an effect of growth factor induced activation of connective tissue cells? Ann Rheum Dis (1985) 1.20
Analysis of cell-growth-phase-related variations in hyaluronate synthase activity of isolated plasma-membrane fractions of cultured human skin fibroblasts. Biochem J (1986) 1.12
Subcellular localization of hyaluronate synthetase in oligodendroglioma cells. J Biol Chem (1984) 1.08
Enhanced synthesis and extracellular accumulation of hyaluronic acid during stimulation of quiescent human fibroblasts by mouse epidermal growth factor. J Cell Physiol (1976) 1.06
Stimulation of DNA synthesis in cultured primary human mesothelial cells by specific growth factors. FASEB J (1988) 1.06
Dissimilar peptide growth factors can induce normal human mesothelial cell multiplication. In Vitro Cell Dev Biol (1988) 1.05
Hyaluronate-cell interactions and growth factor regulation of hyaluronate synthesis during limb development. Ciba Found Symp (1989) 1.02
Evidence for rapid metabolic turnover of hyaluronate synthetase in Swarm rat chondrosarcoma chondrocytes. Biochem J (1986) 0.99
Effects of adenosine 3':5'-cyclic monophosphate and serum on synthesis of hyaluronic acid in confluent rat fibroblasts. Biochem J (1977) 0.99
Hyaluronate synthetase inhibition by normal and transformed human fibroblasts during growth reduction. J Cell Biol (1987) 0.98
Expression of c-sis (PDGF B-chain) and PDGF A-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors. Oncogene (1988) 0.97
Human malignant mesothelioma cell lines express PDGF beta-receptors whereas cultured normal mesothelial cells express predominantly PDGF alpha-receptors. Oncogene (1991) 0.96
Characterization of a high-Mr plasma-membrane-bound protein and assessment of its role as a constituent of hyaluronate synthase complex. Biochem J (1986) 0.95
Identification and regulation of the eukaryotic hyaluronate synthase. Ciba Found Symp (1989) 0.92
A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive disease. Cancer (1989) 0.90
Differential expression of platelet-derived growth factor alpha- and beta- receptors on fat-storing cells and endothelial cells of rat liver. Exp Cell Res (1991) 0.90
Studies on glycosaminoglycans of regenerating rabbit ear cartilage. Dev Biol (1981) 0.89
Hyaluronic acid content of effusions as a diagnostic aid for malignant mesothelioma. Cancer Res (1985) 0.88
Cooperative enhancement of hyaluronic acid synthesis by combined use of IGF-I and EGF, and inhibition by tyrosine kinase inhibitor genistein, in cultured mesothelial cells from rabbit pericardial cavity. J Cell Sci (1991) 0.88
The effect of the tumor promoter, phorbol myristate acetate (PMA), on hyaluronic acid (HA) synthesis by chicken embryo fibroblasts. Exp Cell Res (1983) 0.87
Concentration of hyaluronan in the serum of untreated cancer patients with special reference to patients with mesothelioma. Cancer (1988) 0.85
Insulin-like growth factor I (IGF-I) enhances hyaluronic acid synthesis in rabbit pericardium. Biochim Biophys Acta (1989) 0.83
Stimulatory effect of vanadate on hyaluronic acid synthesis in mesothelial cells from rabbit pericardium. Biochem Int (1988) 0.80
Significance of the quantification and demonstration of hyaluronic acid in tissue specimens for the diagnosis of pleural mesothelioma. Am Rev Respir Dis (1979) 0.78
Electrophoresis of tissue glycosaminoglycans as an aid in the diagnosis of mesotheliomas. Cancer (1979) 0.77
Hyaluronan: its nature, distribution, functions and turnover. J Intern Med (1997) 4.55
Physiological function of connective tissue polysaccharides. Physiol Rev (1978) 3.57
The interaction between polysaccharides and other macromolecules. 9. The exclusion of molecules from hyaluronic acid gels and solutions. Biochem J (1964) 2.24
Density gradients prepared from colloidal silica particles coated by polyvinylpyrrolidone (Percoll). Anal Biochem (1978) 2.15
The molecular-weight-dependence of the anti-coagulant activity of heparin. Biochem J (1978) 2.03
Determination of the structure of agarose gels by gel chromatography. Biochim Biophys Acta (1967) 1.80
Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res (1983) 1.74
Fractionation of dextran and Ficoll by chromatography on Sephadex G-200. Biochim Biophys Acta (1967) 1.70
Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest (1985) 1.70
The incidence of chronic post-sternotomy pain after cardiac surgery--a prospective study. Acta Anaesthesiol Scand (2001) 1.69
Scavenger functions of the liver endothelial cell. Biochem J (1990) 1.59
Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J (1981) 1.53
Concentration and relative molecular mass of hyaluronate in lymph and blood. Biochem J (1986) 1.50
Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J (1984) 1.50
Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts. Biochem J (1989) 1.49
Nomenclature of hyaluronic acid. Biochem J (1986) 1.45
Eosinophil granule proteins in cardiopulmonary bypass with and without heparin coating. Ann Thorac Surg (1995) 1.40
The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett (1997) 1.36
Binding of hyaluronate and chondroitin sulphate to liver endothelial cells. Biochem J (1986) 1.36
Turnover and metabolism of hyaluronan. Ciba Found Symp (1989) 1.34
The viability of cells grown or centrifuged in a new density gradient medium, Percoll(TM). Exp Cell Res (1977) 1.34
Elimination of hyaluronic acid from the blood stream in the human. Clin Exp Pharmacol Physiol (1984) 1.31
Precipitation of some plasma proteins by the addition of dextran or polyethylene glycol. Biochim Biophys Acta (1967) 1.31
The properties and turnover of hyaluronan. Ciba Found Symp (1986) 1.26
Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J (1988) 1.25
X-ray-diffraction patterns from chondroitin 4-sulphate, dermatan sulphate and heparan sulphate. Biochem J (1973) 1.20
In vitro studies on the transport of macromolecules through the connective tissue. Fed Proc (1966) 1.20
Uptake of circulating hyaluronic acid by the rat liver. Cellular localization in situ. Cell Tissue Res (1985) 1.16
Conformational transitions of polynucleotides in polymer media. Eur J Biochem (1974) 1.14
Images in cardiovascular medicine. Papillary fibroelastoma as an unusual source of repeated pulmonary embolism. Circulation (1994) 1.11
Atelectasis is a major cause of hypoxemia and shunt after cardiopulmonary bypass: an experimental study. Anesthesiology (1997) 1.11
Tissue uptake of circulating hyaluronic acid. A whole body autoradiographic study. Cell Tissue Res (1983) 1.10
Hyaluronan in the rat with special reference to the skin. Acta Physiol Scand (1988) 1.10
Stimulation of hyaluronan biosynthesis by platelet-derived growth factor-BB and transforming growth factor-beta 1 involves activation of protein kinase C. Biochem J (1995) 1.09
On the molecular-weight-dependence of the anticoagulant activity of heparin. Biochem J (1979) 1.09
Matrilinear phylogeography of Atlantic salmon (Salmo salar L.) in Europe and postglacial colonization of the Baltic Sea area. Mol Ecol (2001) 1.09
Interaction between proteins and glycosaminoglycans. Fed Proc (1977) 1.08
Accumulation of hyaluronan (hyaluronic acid) in the lung in adult respiratory distress syndrome. Am Rev Respir Dis (1989) 1.06
Complement activation during cardiopulmonary bypass: effects of immobilized heparin. Ann Thorac Surg (1994) 1.06
Localization and synthesis of hyaluronic acid in the cumulus cells and mural granulosa cells of the preovulatory follicle. Dev Biol (1992) 1.05
Elevated levels of plasma hyaluronan in septicaemia. Scand J Clin Lab Invest (1988) 1.03
Human mesothelioma cells produce factors that stimulate the production of hyaluronan by mesothelial cells and fibroblasts. Cancer Res (1993) 1.02
The binding of chondroitin sulphate to collagen. FEBS Lett (1975) 1.01
Variable FHIT transcripts in non-neoplastic tissues. Genes Chromosomes Cancer (1997) 0.99
Enzyme reactions in polymer media. Eur J Biochem (1971) 0.99
Morphological studies on endocytosis of chondroitin sulphate proteoglycan by rat liver endothelial cells. Cell Tissue Res (1988) 0.97
The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14. Cancer Res (1996) 0.96
High incidence of Chlamydia pneumoniae in sclerotic heart valves of patients undergoing aortic valve replacement. Scand J Infect Dis (1997) 0.95
On the restriction of the rotational diffusion of proteins in polymer networks. Eur J Biochem (1972) 0.94
Diffusion of dextran in concentrated solutions. Eur J Biochem (1976) 0.93
Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study. J Thorac Cardiovasc Surg (1997) 0.93
Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age. Scand J Clin Lab Invest (1992) 0.92
The catabolic fate of hyaluronic acid. Connect Tissue Res (1986) 0.91
Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery. Scand Cardiovasc J (2000) 0.91
Solubility of proteins in the presence of polysaccharides. Fed Proc (1966) 0.91
Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: a clinical study. Ann Thorac Surg (1993) 0.91
Catabolism of hyaluronan in the knee joint of the rabbit. Matrix (1992) 0.91
Correlation between increased hyaluronan localized in arthritic synovium and the presence of proliferating cells. A role for macrophage-derived factors. Arthritis Rheum (1992) 0.91
Hyaluronan efflux from canine lung with increased hydrostatic pressure and saline loading. Am J Respir Crit Care Med (1994) 0.91
Differential expression of platelet-derived growth factor alpha- and beta- receptors on fat-storing cells and endothelial cells of rat liver. Exp Cell Res (1991) 0.90
Diffucison of OXYGEN, Nitrogen and water in hyluronate solutions. Biochim Biophys Acta (1975) 0.89
Quality of life in survivors of thoracic aortic surgery. Ann Thorac Surg (1999) 0.89
Enzymic pathways of hyaluronan catabolism. Ciba Found Symp (1989) 0.89
The localization of hyaluronan in normal and rejected human kidneys. Transplantation (1990) 0.88
Exclusion of dextrans by meshworks of collagenous fibres. Biochem J (1977) 0.88
Determination of hyaluronic acid in the microgram range. Anal Biochem (1969) 0.87
Seven different assays of hyaluronan compared for clinical utility. Clin Chem (1992) 0.86
Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. J Thorac Cardiovasc Surg (1992) 0.86
Concentration of hyaluronan in the serum of untreated cancer patients with special reference to patients with mesothelioma. Cancer (1988) 0.85
Increased lymphatic elimination of interstitial hyaluronan during E. coli sepsis in sheep. Am J Physiol (1989) 0.85
Energy-related metabolites during and after induced myocardial infarction with special emphasis on the reperfusion injury after extracorporeal circulation. Acta Physiol Scand (2001) 0.85
Lymphatic hyaluronan flux from skin increases during increased lymph flow induced by intravenous saline loading. Int J Microcirc Clin Exp (1994) 0.85
Concentration and turnover of intraperitoneal hyaluronan during inflammation. Inflammation (1992) 0.85
Hyaluronan in prenodal lymph from skin: changes with lymph flow. Am J Physiol (1990) 0.84
Differential synthesis and binding of hyaluronan by human breast cancer cell lines. Oncol Rep (1996) 0.84
Use of a vital capacity maneuver to prevent atelectasis after cardiopulmonary bypass: an experimental study. Anesthesiology (1998) 0.84
Preparation of biologically intact radioiodinated hyaluronan of high specific radioactivity: coupling of 125I-tyramine-cellobiose to amino groups after partial N-deacetylation. Anal Biochem (1988) 0.84
Effect of increased hydrostatic pressure on lymphatic elimination of hyaluronan from sheep lung. J Appl Physiol (1985) (1988) 0.83
Assay and properties of N-acetylglucosamine-6-phosphate deacetylase from rat liver. Anal Biochem (1987) 0.83
Marked increase of plasma hyaluronan after major thermal injury and infusion therapy. J Surg Res (1991) 0.83
Biochemical characterization and tissue distribution of the scleredema in a case of Buschke's disease. Acta Derm Venereol (1987) 0.82
Removal of hyaluronic acid from the circulation in rheumatoid disease and primary biliary cirrhosis. J Lab Clin Med (1986) 0.82
Lung hyaluronan and water content in preterm and term rabbit pups exposed to oxygen or air. Pediatr Res (1998) 0.82
Duraflo II coating of cardiopulmonary bypass circuits reduces complement activation, but does not affect the release of granulocyte enzymes : a European multicentre study. Eur J Cardiothorac Surg (1997) 0.82
Removal rate of [3H]hyaluronan injected subcutaneously in rabbits. Am J Physiol (1990) 0.82
Kinetics of circulating hyaluronan in humans. 4. Eur J Clin Invest (1994) 0.82
Hyaluronan: relationship to hemodynamics and survival in porcine injury and sepsis. Crit Care Med (1992) 0.80
Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. Artif Organs (1990) 0.80
Hyaluronan in human cerebrospinal fluid. Acta Neurol Scand (1996) 0.80
A study of micelles of sodium taurodeoxycholate in the ultracentrifuge. Biochim Biophys Acta (1965) 0.80
The rotational diffusion of albumin in solutions of connective-tissue polysaccharides. Eur J Biochem (1973) 0.79
Effects of heparin-coating of cardiopulmonary bypass circuits on leukocytes during simulated extracorporeal circulation. Cardiovasc Surg (1997) 0.79
A pharmacokinetic model of intravenously administered hyaluronan in sheep. Pharm Res (1989) 0.79
Increased plasma hyaluronan in severe pre-eclampsia and eclampsia. Scand J Clin Lab Invest (2001) 0.79
Lung hyaluronan during development: a quantitative and morphological study. Am J Physiol (1991) 0.79
An experimental technique to study the turnover of concentrated hyaluronan in the anterior chamber of the rabbit. Exp Eye Res (1988) 0.79
Partial characterization of reaction products formed by the degradation of hyaluronic acid with ascorbic acid. Biochim Biophys Acta (1969) 0.79
An estimate of the enthalpic contribution to the interaction between dextran and albumin. Biochem J (1978) 0.78
Thrombin generation during cardiopulmonary bypass using heparin-coated or standard circuits. Scand J Thorac Cardiovasc Surg (1995) 0.78